Trial of Intensive Blood-Pressure Control in Older Patients with HypertensionWeili Zhang, Jun Cai, Jie Ren et al.|New England Journal of Medicine|2021Cited by 742
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trialMarkus P. Schlaich, Thomas Guldager Lauridsen, M Bellet et al.|The Lancet|2022Cited by 223